143 related articles for article (PubMed ID: 20501760)
1. Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population.
Le Marchand L; Wang H; Rinaldi S; Kaaks R; Vogt TM; Yokochi L; Decker R
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1471-7. PubMed ID: 20501760
[TBL] [Abstract][Full Text] [Related]
2. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
3. Association of plasma vitamin B6 with risk of colorectal adenoma in a multiethnic case-control study.
Le Marchand L; Wang H; Selhub J; Vogt TM; Yokochi L; Decker R
Cancer Causes Control; 2011 Jun; 22(6):929-36. PubMed ID: 21437631
[TBL] [Abstract][Full Text] [Related]
4. C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):750-5. PubMed ID: 16614119
[TBL] [Abstract][Full Text] [Related]
5. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort.
DeLellis Henderson K; Rinaldi S; Kaaks R; Kolonel L; Henderson B; Le Marchand L
Nutr Cancer; 2007; 58(2):136-45. PubMed ID: 17640159
[TBL] [Abstract][Full Text] [Related]
7. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
9. Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population.
Ognjanovic S; Yamamoto J; Saltzman B; Franke A; Ognjanovic M; Yokochi L; Vogt T; Decker R; Le Marchand L
Cancer Causes Control; 2010 Jul; 21(7):1131-8. PubMed ID: 20333461
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk.
Ochs-Balcom HM; Vaughn CB; Nie J; Chen Z; Thompson CL; Parekh N; Tracy R; Li L
Cancer Causes Control; 2014 Feb; 25(2):161-70. PubMed ID: 24194259
[TBL] [Abstract][Full Text] [Related]
11. Association of a common polymorphism in the human GH1 gene with colorectal neoplasia.
Le Marchand L; Donlon T; Seifried A; Kaaks R; Rinaldi S; Wilkens LR
J Natl Cancer Inst; 2002 Mar; 94(6):454-60. PubMed ID: 11904318
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.
Giovannucci E; Pollak MN; Platz EA; Willett WC; Stampfer MJ; Majeed N; Colditz GA; Speizer FE; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):345-9. PubMed ID: 10794477
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American men.
Nomura AM; Stemmermann GN; Lee J; Pollak MN
Am J Epidemiol; 2003 Sep; 158(5):424-31. PubMed ID: 12936897
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men.
Teramukai S; Rohan T; Lee KY; Eguchi H; Oda T; Kono S
Jpn J Cancer Res; 2002 Nov; 93(11):1187-94. PubMed ID: 12460458
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of insulin-like growth factor and insulin-like growth factor binding protein 3 and recurrent colorectal adenomas.
Flood A; Mai V; Pfeiffer R; Kahle L; Rosen CJ; Lanza E; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1493-8. PubMed ID: 18559566
[TBL] [Abstract][Full Text] [Related]
18. Elevated C-peptide and insulin predict increased risk of colorectal adenomas in normal mucosa.
Vidal AC; Lund PK; Hoyo C; Galanko J; Burcal L; Holston R; Massa B; Omofoye O; Sandler RS; Keku TO
BMC Cancer; 2012 Sep; 12():389. PubMed ID: 22950808
[TBL] [Abstract][Full Text] [Related]
19. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
[TBL] [Abstract][Full Text] [Related]
20. Plasma insulin-like growth factor I is inversely associated with colorectal adenoma recurrence: a novel hypothesis.
Jacobs ET; MartÃnez ME; Alberts DS; Ashbeck EL; Gapstur SM; Lance P; Thompson PA
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):300-5. PubMed ID: 18250342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]